Clarification: Amgen-Onyx story

NEW YORK (AP) — In a story Aug. 25, The Associated Press reported that Onyx Pharmaceuticals and Pfizer Inc. are studying a potential breast cancer treatment, called palbociclib, and oprozomib, a potential multiple myeloma drug that is in early clinical testing.